Smartlab Europe

Press Releases

AT & IT China 2020, to be held alongside CPhI & P-MEC China 2020, will showcase Intelligent Pharma High-tech solutions

AT & IT China 2020, organized by Informa Markets and China Chamber of Commerce for Import & Export of Medicines & Health Products and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd., to take place at the...

Airnov to debut new branding and vision at Pharmapack at Stand J50

Airnov Healthcare Packaging (previously Clariant Healthcare Packaging) will reveal its new visual identity and branding to industry partners along with its portfolio of specialty products that prevent packaged pharmaceuticals from degradation due to moisture and oxygen at the Pharmapack...

Pharma Nest 2020 – International Conference honors Bangladeshi CEO and Philanthropist

CEO of Integro Pharma Dr Zareen Delawar Hussain has recently received the Women Excellency Award at an international conference titled Pharma Nest 2020. Dr. Zareen Delawar Hussain, was the Chief Guest at an International Conference titled ‘Pharma Nest 2020: Shaping...

CytoviaTherapeutics and the University of California enter into a partnership to develop precision gene-edited CAR-NK celltherapy

CytoviaTherapeutics,a biopharmaceutical company, and the University of California,San Francisco(UCSF) announced that they have entered a 3-year research partnership to develop novel precision gene editing to improve the performance, safety and persistence of Natural Killer(NK) cells and Chimeric Antigen Receptor(CAR)-NK...

WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announced the opening of its large-scale oligonucleotide active pharmaceutical ingredient (API) manufacturing facility in Changzhou, China. This significant milestone marks WuXi STA’s establishment of a comprehensive...

Bayer and Exscientia collaborate to leverage the potential of AI in cardiovascular and oncology drug discovery

Bayer and Exscientia Ltd., a UK-based Artificial Intelligence (AI)-driven drug discovery company, have entered into a three-year, multi-target collaboration. The partners will work on early research projects combining Exscientia’s proprietary AI drug discovery platform and drug design know-how with...

Mundipharma enters partnership with Samsung Bioepis to expand biosimilars into Hong Kong and Taiwan

Mundipharma announced a partnership with Samsung Bioepis to commercialize Samsung Bioepis’ first-wave biosimilar candidates in Taiwan and Hong Kong. The partnership covers Samsung Bioepis’ biosimilar candidates in the field of immunology and oncology, including SB5 (adalimumab), SB4 (etanercept), SB3 (trastuzumab),...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »